Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity

NCT00092222 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

75

Enrollment

NIH

Sponsor class

Conditions

Lymphoproliferative Disorder
HHV-8
Malignancy
HIV

Interventions

DRUG: Etoposide
DRUG: Interferon-alpha
DRUG: Rituximab
DRUG: Zidovudine
DRUG: Liposomal Doxorubicin
DRUG: Bortezomib
DRUG: Valganciclovir
DRUG: Doxorubicin
DRUG: Vincristine
DRUG: Cyclophosphamide
DRUG: Filgrastim (G-CSF)
DRUG: Prednisone
DRUG: Sirolimus
OTHER: Observation Only

Sponsor

National Cancer Institute (NCI)